<b>Structural Determinants of Non-Covalent PPARγ Inverse Agonism and Their Therapeutic Implications</b>

<p dir="ltr">Peroxisome proliferator-activated receptor gamma (PPARγ) is a validated therapeutic target for type 2 diabetes (T2D), but current FDA-approved agonists are limited by adverse effects. SR10171, a non-covalent partial inverse agonist with modest binding potency, improves i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Kuang-Ting Kuo (21682520) (author)
Diğer Yazarlar: Patrick R. Griffin (16519783) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller